Betta IPO Tells Tale Of Shifting Strategy By China Innovators
This article was originally published in The Pink Sheet Daily
Executive Summary
As a national innovation darling, Betta Pharma is gearing up to a much-hyped public listing in China. Combing through its 300-plus page prospectus, however, unveils a different Betta striving to diversify amid looming competition and price pressure.